Neuroendocrine Tumor Clinical Trials

Find Neuroendocrine Tumor Clinical Trials Near You

Establishment of a Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ at 18 years old,

• Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,

• Patient treated as part of his treatment for:

‣ thyroid cancer,

⁃ a neuroendocrine tumor or

⁃ prostate cancer.

• Patient having accepted the complementary blood sample,

• Patient having given his informed, written and express consent.

Locations
Other Locations
France
Hopital Haut Lévêque
RECRUITING
Bordeaux
Hôpital LaTimone
NOT_YET_RECRUITING
Marseille
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
RECRUITING
Montpellier
Institut Universitaire du Cancer de Toulouse
RECRUITING
Toulouse
Contact Information
Primary
Aurore MOUSSION
DRCI-icm105@icm.unicancer.fr
0467613102
Time Frame
Start Date: 2019-10-28
Estimated Completion Date: 2026-10
Participants
Target number of participants: 350
Treatments
Experimental: Biological collection
Biological collection~For all the patients include in the study :~samples of blood samples collected before and during treatment. In parallel to this biological collection, standardized clinical data will be entered into a database~Ancillary study :~For metastatic thyroïd cancer and neuroendocrine tumor : anapath blocks of the initial diagnosis will be archived and dosimetric data will be collected for the cycle 1 For neuroendocrine tumor : blood sample additionnal will be realized at the cycle 1 (pre and post treatment)
Sponsors
Leads: Institut du Cancer de Montpellier - Val d'Aurelle

This content was sourced from clinicaltrials.gov